Skip to main content

Table 1 Relation of SIRT1, SIRT2, SIRT3, SIRT4, SIRT5, SIRT6, and SIRT7 expression with overall survival Hazard Ratio in melanoma patients, according to data reported in GEPIA2 database [43]. SIRT2 shows strong and significant HR

From: Nicotinamide inhibits melanoma in vitro and in vivo

Gene name

Hazard Ratio for high expression

P

N. of patients with high expression

N. of patients with low expression

SIRT1

0.72

0.074

138

114

SIRT2

1.9

0.0004

138

115

SIRT3

0.75

0.12

138

114

SIRT4

0.91

0.6

137

109

SIRT5

0.98

0.93

138

115

SIRT6

0.98

0.93

138

115

SIRT7

0.91

0.63

138

115